Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Longeveron LLC
LGVNCurrent price
1.75 USD
+0.12 USD (+7.36%)
Last closed
1.61 USD
Company
www.longeveron.com
ISIN
US54303L2034
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
24 381 376 USD
Yield for 12 month
+3.55 %
1Y
3Y
5Y
10Y
15Y
LGVN
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors which is in phase 1 clinical trial to treat hypoplastic left heart syndrome; completed phase 2a clinical trial to treat Alzheimer's disease, as well as in phase 2b clinical trial to treat aging frailty. The company was incorporated in 2014 and is headquartered in Miami, Florida. Address: Life Science & Technology Park, Miami, FL, United States, 33136
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
8.88 USDP/E ratio
–Dividend Yield
–Current Year
+2 392 000 USD
Last Year
+709 000 USD
Current Quarter
+603 000 USD
Last Quarter
+773 000 USD
Current Year
+1 884 000 USD
Last Year
+221 000 USD
Current Quarter
+530 000 USD
Last Quarter
+682 000 USD
Key Figures LGVN
1 year
3 years
5 years
10 years
EBITDA
-15 564 000 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-54.87 %
PEG Ratio
–
Return On Equity TTM
-111.59 %
Wall Street Target Price
8.88 USD
Revenue TTM
2 392 000 USD
Book Value
1.47 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
857.10 %
Dividend Yield
–
Gross Profit TTM
1 884 000 USD
Earnings per share
-2.62 USD
Diluted Eps TTM
-2.62 USD
Most Recent Quarter
IV 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics LGVN
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History LGVN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
1:10
Payout Ratio TTM
–
Last Split Date
27.03.2024
Stock Valuation LGVN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
2.76
Price Sales TTM
10.19
Enterprise Value EBITDA
-49.61
Price Book MRQ
1.11
Financials LGVN
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators LGVN
For 52 weeks
0.77 USD
6.40 USD
50 Day MA
1.55 USD
Shares Short Prior Month
736 838
200 Day MA
2.02 USD
Short Ratio
1.37
Shares Short
634 445
Short Percent
5.03 %
BeatStart